Advanced Enzyme Technologies LimitedADVENZYMESImprovingNotablemateriality 69 out of 100
Further to the intimation letter dated August 02, 2025, we hereby inform that the Companyhas completed an…
Capitalrights issue
As filed
Further to the intimation letter dated August 02, 2025, we hereby inform that the Companyhas completed an additional investment of ₹ 2.5 million in the wholly owned subsidiaryof the Company Adva
Why it matters
CapitSignal interpretationExisting holders can maintain their stake only by putting in more money; those who do not subscribe are diluted.